Recurrent Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC (NCT06912087) | University of Chicago | 2025-09-29 |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (NCT05323253) | Alpha Tau Medical LTD. | 2022-09-21 |
Track Recurrent Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.